Stock Scorecard
Stock Summary for ANI Pharmaceuticals Inc (ANIP) - $90.00 as of 8/15/2025 10:03:55 AM EST
Total Score
7 out of 30
Safety Score
48 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for ANIP
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for ANIP
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for ANIP
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for ANIP
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for ANIP (48 out of 100)
| Stock Price Rating (Max of 10) | 9 |
| Historical Stock Price Rating (Max of 10) | 8 |
| Stock Price Trend (Max of 10) | 9 |
| Book Value (Max of 10) | 7 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 3 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 2 |
| Trading Volume (Max of 10) | 6 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for ANIP
Financial Details for ANIP
Company Overview |
|
|---|---|
| Ticker | ANIP |
| Company Name | ANI Pharmaceuticals Inc |
| Country | USA |
| Description | ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets brand-name and generic prescription pharmaceuticals in the United States and Canada. The company is headquartered in Baudette, Minnesota. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 6/30/2025 |
| Next Earnings Date | 11/5/2025 |
Stock Price History |
|
| Last Day Price | 90.00 |
| Price 4 Years Ago | 46.08 |
| Last Day Price Updated | 8/15/2025 10:03:55 AM EST |
| Last Day Volume | 605,121 |
| Average Daily Volume | 521,931 |
| 52-Week High | 90.23 |
| 52-Week Low | 52.50 |
| Last Price to 52 Week Low | 71.43% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 41.62 |
| Sector PE | 58.94 |
| 5-Year Average PE | 19.77 |
| Free Cash Flow Ratio | 8.96 |
| Industry Free Cash Flow Ratio | 16.38 |
| Sector Free Cash Flow Ratio | 30.80 |
| Current Ratio Most Recent Quarter | 2.54 |
| Total Cash Per Share | 10.04 |
| Book Value Per Share Most Recent Quarter | 21.70 |
| Price to Book Ratio | 4.39 |
| Industry Price to Book Ratio | 31.90 |
| Sector Price to Book Ratio | 27.60 |
| Price to Sales Ratio Twelve Trailing Months | 2.58 |
| Industry Price to Sales Ratio Twelve Trailing Months | 102.07 |
| Sector Price to Sales Ratio Twelve Trailing Months | 32.11 |
| Analyst Buy Ratings | 3 |
| Analyst Strong Buy Ratings | 4 |
Share Statistics |
|
| Total Shares Outstanding | 21,688,800 |
| Market Capitalization | 1,951,992,000 |
| Institutional Ownership | 102.10% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 4.44% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | -16.90% |
| Annual Earnings Growth | -198.63% |
| Reported EPS 12 Trailing Months | -0.69 |
| Reported EPS Past Year | 2.49 |
| Reported EPS Prior Year | 3.02 |
| Net Income Twelve Trailing Months | -11,031,000 |
| Net Income Past Year | -18,522,000 |
| Net Income Prior Year | 18,779,000 |
| Quarterly Revenue Growth YOY | 53.10% |
| 5-Year Revenue Growth | 24.36% |
| Operating Margin Twelve Trailing Months | 7.18% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 217,797,000 |
| Total Cash Past Year | 144,861,000 |
| Total Cash Prior Year | 221,121,000 |
| Net Cash Position Most Recent Quarter | -390,549,000 |
| Net Cash Position Past Year | -470,059,000 |
| Long Term Debt Past Year | 614,920,000 |
| Long Term Debt Prior Year | 284,819,000 |
| Total Debt Most Recent Quarter | 608,346,000 |
| Equity to Debt Ratio Past Year | 0.41 |
| Equity to Debt Ratio Most Recent Quarter | 0.42 |
| Total Stockholder Equity Past Year | 428,530,000 |
| Total Stockholder Equity Prior Year | 457,599,000 |
| Total Stockholder Equity Most Recent Quarter | 436,757,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 107,354,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 4.95 |
| Free Cash Flow Past Year | 47,064,000 |
| Free Cash Flow Prior Year | 100,448,000 |
Options |
|
| Put/Call Ratio | 2.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 5.16 |
| MACD Signal | 2.55 |
| 20-Day Bollinger Lower Band | 52.73 |
| 20-Day Bollinger Middle Band | 67.27 |
| 20-Day Bollinger Upper Band | 81.81 |
| Beta | 0.61 |
| RSI | 83.54 |
| 50-Day SMA | 61.54 |
| 150-Day SMA | 55.58 |
| 200-Day SMA | 50.68 |
System |
|
| Modified | 8/14/2025 5:24:31 PM EST |